Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study.
Cardiovascular diseases
Diabetes
Epidemiology
Hypertension
Lifetime risk
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
30
03
2020
accepted:
03
06
2020
revised:
26
05
2020
pubmed:
6
7
2020
medline:
13
10
2021
entrez:
5
7
2020
Statut:
ppublish
Résumé
Lifetime risk is an informative estimate to motivate people to change lifestyle behaviors, especially from a younger age, in public health education. The impact of the combination of hypertension and diabetes on the lifetime risk of cardiovascular mortality has not been investigated in Asian populations. A pooled analysis of individual data from nine cohorts was performed. A total of 57,339 Japanese men and women were eligible for the analysis. We used the modified Kaplan-Meier approach and estimated the remaining lifetime risk of cardiovascular mortality starting from the index age of 35 years. Participants were classified into four categories defined by hypertension and diabetes. The lifetime risk was increased in the order of those without either risk, those without hypertension but with diabetes, those with hypertension but without diabetes, and those with both risks. The lifetime risk of cardiovascular mortality at the 35-year index age was as follows: 7.8% in men and 6.2% in women for those without either hypertension or diabetes, 13.2% in men and 9.5% in women for those without hypertension but with diabetes, 17.2% in men and 11.7% in women for those with hypertension but without diabetes, and 19.4% in men and 15% in women for those with both risks. These findings reinforce the need for a life-course perspective in the management of hypertension and diabetes from a younger age.
Identifiants
pubmed: 32620896
doi: 10.1038/s41440-020-0502-5
pii: 10.1038/s41440-020-0502-5
doi:
Types de publication
Journal Article
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Pagination
1437-1444Références
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
pubmed: 12493255
Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. N Engl J Med. 2019;381:243–51.
pubmed: 31314968
Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, et al. What has made the population of Japan healthy? Lancet. 2011;378:1094–105.
pubmed: 21885105
Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JCN, Chia KS, et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care. 2016;39:472–85.
pubmed: 26908931
Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053–9.
pubmed: 11304502
Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. Hypertens Res. 2017;40:795–806.
pubmed: 28701739
Iimura O. Insulin resistance and hypertension in Japanese. Hypertens Res. 1996;19(Suppl 1):S1–8.
pubmed: 9240755
Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, et al. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hypertens Res. 2010;33:1238–43.
pubmed: 20927111
Vaccaro O, Stamler J, Neaton JD. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). Int J Epidemiol. 1998;27:636–41.
pubmed: 9758118
Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr., Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935–59.
pubmed: 24239921
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.
pubmed: 27567407
Harada A, Ueshima H, Kinoshita Y, Miura K, Takayoshi O, Asayama K, et al. Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study. Hypertens Res. 2019;42:567–79.
pubmed: 30760890
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooki Y, et al. The Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
pubmed: 31375757
Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Umemoto S, et al. Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2017. J Atheroscler Thromb. 2018;25:846–984.
pubmed: 30135334
pmcid: 6143773
Berry JD, Liu K, Folsom AR, Polak JF, Lewis CE, Shea S, et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation. 2009;119:382–9.
pubmed: 19139385
pmcid: 2836265
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Revi Esp Cardiol. 2017;70:115.
Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB Sr. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 2008;31:1582–4.
pubmed: 18458146
pmcid: 2494632
Turin TC, Okamura T, Rumana N, Afzal AR, Watanabe M, Higashiyama A, et al. Diabetes and lifetime risk of coronary heart disease. Prim Care Diabetes. 2017;11:461–6.
pubmed: 28545843
Turin TC, Okamura T, Rumana N, Afzal AR, Watanabe M, Higashiyama A, et al. Diabetes and lifetime risk of stroke and subtypes in an urban middle-aged population. J Diabetes Complications. 2017;31:831–5.
pubmed: 28222941
Allen N, Berry JD, Ning H, Van Horn L, Dyer A, Lloyd-Jones DM. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease: the cardiovascular lifetime risk pooling project. Circulation. 2012;125:37–44.
pubmed: 22184621
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345–50.
pubmed: 16397184
Takahashi I, Geyer SM, Nishi N, Ohshita T, Takahashi T, Akahoshi M, et al. Lifetime risk of stroke and impact of hypertension: estimates from the adult health study in Hiroshima and Nagasaki. Hypertens Res. 2011;34:649–54.
pubmed: 21326305
Turin TC, Okamura T, Afzal AR, Rumana N, Watanabe M, Higashiyama A, et al. Hypertension and lifetime risk of stroke. J Hypertens. 2016;34:116–22.
pubmed: 26556566
Turin TC, Okamura T, Afzal AR, Rumana N, Watanabe M, Higashiyama A, et al. Impact of hypertension on the lifetime risk of coronary heart disease. Hypertens Res. 2016;39:548–51.
pubmed: 26960917
Satoh M, Ohkubo T, Asayama K, Murakami Y, Sugiyama D, Tamada M, et al. Lifetime risk of stroke and coronary heart disease deaths according to blood pressure level: EPOCH-JAPAN (Evidence for Cardiovascular Prevention From Observational Cohorts in Japan). Hypertension. 2019;73:52–9.
pubmed: 30763510
Hirakawa Y, Ninomiya T, Kiyohara Y, Murakami Y, Saitoh S, Nakagawa H, et al. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: an overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN). J Epidemiol. 2017;27:123–9.
pubmed: 28142033
pmcid: 5350618
Hirata A, Sugiyama D, Watanabe M, Tamagoshy A, Iso H, Kotani K, et al. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH-JAPAN study. J Clin Lipido. 2018;12:674–84.e5.
Hirata T, Sugiyama D, Nagasawa S-Y, Murakami Y, Saitoh S, Okayama A, et al. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan. Eur J Epidemiol. 2017;32:547–57.
pubmed: 27709448
Asayama K, Ohkubo T, Satoh A, Tanaka S, Higashiyama A, Okayama A, et al. Cardiovascular risk and blood pressure lowering treatment among elderly individuals: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan. J Hypertens. 2018;36:410–8.
pubmed: 28877077
Murakami Y, Hozawa A, Okamura T, Ueshima H, Evidence for Cardiovascular Prevention from Observational Cohorts in Japan Research Group (EPOCH-JAPAN). Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies. Hypertension. 2008;51:1483–91.
pubmed: 18443234
Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med. 2012;366:321–9.
pubmed: 22276822
pmcid: 3336876
Nagai M, Murakami Y, Tamakoshi A, Kiyohara Y, Yamada M, Ukawa S, et al. Fasting but not casual blood glucose is associated with pancreatic cancer mortality in Japanese: EPOCH-JAPAN. Cancer Causes Control. 2017;28:625–33.
pubmed: 28352981
Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518–25.
pubmed: 9056605
Arima H, Tanizaki Y, Kiyohara Y, Tsuchihashi T, Kato I, Kubo M, et al. Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study. Arch Intern Med. 2003;163:361–6.
pubmed: 12578518
Kuriyama S, Shimazu T, Ohmori K, Kikucho N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296:1255–65.
pubmed: 16968850
Beiser A, D’Agostino RB Sr., Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer’s disease in the Framingham Study. The practical incidence estimators (PIE) macro. Stat Med. 2000;19:1495–522.
pubmed: 10844714
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (adult treatment panel III). JAMA. 2001;285:2486–97.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:3168–209.
pubmed: 30423391
Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118:2702–9.
pubmed: 19106393
pmcid: 3096564
Sone H, Tanaka S, Tanaka S, Iimuro S, Oida K, Yamasaki Y, et al. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab. 2011;96:3448–56.
pubmed: 21865372
Honda T, Yoshida D, Hata J, Kirakawa Y, Ishida Y, Shibata M, et al. Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: the Hisayama study. Atherosclerosis. 2018;279:38–44.
pubmed: 30408715
Saito I, Yamagishi K, Kokubo Y, Yatsuya H, Iso H, Sawada N. Association between mortality and incidence rates of coronary heart disease and stroke: the Japan Public Health Center-based Prospective (JPHC) study. Int J Cardiol. 2016;222:281–6.
pubmed: 27497111